These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6162106)

  • 1. Production of anti-self H-2 antibodies by hybrid mice immune to a viral tumour.
    Risser R; Grunwald DJ
    Nature; 1981 Feb; 289(5798):563-8. PubMed ID: 6162106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody to Abelson lymphoma cells.
    Lamph WW; Arfsten A; Green PL; Shilling J; Risser R
    Curr Top Microbiol Immunol; 1984; 113():265-8. PubMed ID: 6090067
    [No Abstract]   [Full Text] [Related]  

  • 3. A normal cell protein cross-reactive to the major Abelson murine leukaemia virus gene product.
    Witte ON; Rosenberg NE; Baltimore D
    Nature; 1979 Oct; 281(5730):396-8. PubMed ID: 90344
    [No Abstract]   [Full Text] [Related]  

  • 4. Transformed lymphocytes from Abelson-diseased mice express levels of a B lineage transformation-associated antigen elevated from that found on normal lymphocytes.
    Tidmarsh GF; Dailey MO; Whitlock CA; Pillemer E; Weissman IL
    J Exp Med; 1985 Nov; 162(5):1421-34. PubMed ID: 2997360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of syngeneic tumor regressor serum reactive with the unique determinants of the Abelson murine leukemia virus-encoded P120 protein at the cell surface.
    Witte ON; Rosenberg N; Baltimore D
    J Virol; 1979 Sep; 31(3):776-84. PubMed ID: 92572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic T cell response against lymphoblasts infected with Moloney (Abelson) murine leukemia virus. Methodological aspects and H-2 requirements.
    Stukart MJ; Vos A; Melitef CJ
    Eur J Immunol; 1981 Mar; 11(3):251-7. PubMed ID: 6972310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocytotoxic antibodies produced by H-2 allo-immunisation distinguish between MuLV-positive and -negative substrains of the same H-2 haplotype.
    Ivanyi P; Melief CJ; van Mourik P; Vlug A; de Greeve P
    Nature; 1979 Dec 20-27; 282(5741):843-5. PubMed ID: 229425
    [No Abstract]   [Full Text] [Related]  

  • 9. Transformation by Abelson murine leukemia virus: properties of the transformed cells.
    Raschke WC
    Cold Spring Harb Symp Quant Biol; 1980; 44 Pt 2,():1187-94. PubMed ID: 6253193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cytolytic T lymphocyte clones reactive with Moloney leukemia virus-associated antigens by monoclonal antibodies: a direct approach to the study of H-2 restriction.
    Weiss A; MacDonald HR; Cerottini JC; Brunner KT
    J Immunol; 1981 Feb; 126(2):482-5. PubMed ID: 6450244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L3T4+ T cells regulate Abelson virus-induced lymphomagenesis.
    Infante AJ; Boulware S; Cagle M
    J Immunol; 1988 Apr; 140(7):2462-5. PubMed ID: 2965186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A notable phenomenon recapitulated. A fusion product of a murine lymphoma cell and a leukemia virus-neutralizing antibody-producer host plasma cell formed spontaneously and secreting the specific antibody continuously.
    Sinkovics JG
    Acta Microbiol Immunol Hung; 2005; 52(1):1-40. PubMed ID: 15957233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of antilymphocyte serum on the induction of neoplasms of lymphoreticular tissues.
    Law LW
    Fed Proc; 1970; 29(1):171-4. PubMed ID: 4312738
    [No Abstract]   [Full Text] [Related]  

  • 14. Abelson antigen is expressed on hematopoietic spleen colony-forming cells from mice carrying the Av-2S virus sensitivity gene.
    Risser R
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5350-4. PubMed ID: 228287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to cellular immune response in AKR leukemias.
    Schäfer A; Schmidt W
    Eur J Immunol; 1986 Jul; 16(7):753-9. PubMed ID: 2424771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H-21-linked control of immunological resistance to viral leukemogenesis as a response to preleukemic cells.
    Lonai P; Katz E; Peled A; Haran-Ghera N
    Immunogenetics; 1981 Mar; 12(5-6):423-32. PubMed ID: 6260638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of group- and type-specific antigens in the process of development of viral murine leukemias].
    Gurtsevich VE; Mazurenko NP
    Vopr Onkol; 1973; 19(1):66-70. PubMed ID: 4121908
    [No Abstract]   [Full Text] [Related]  

  • 19. Liposomes as a tool to study the role of membrane presentation in the immunogenicity of a MuLV-related tumor antigen.
    Gerlier D; Bakouche O; Dore JF
    J Immunol; 1983 Jul; 131(1):485-90. PubMed ID: 6190925
    [No Abstract]   [Full Text] [Related]  

  • 20. Cis- and trans-repression of class I major histocompatibility gene expression in Abelson virus-transformed murine leukemia.
    Zeff RA; Zhao YF; Tatake R; Lachman H; Borriello F; Nathenson SG
    Blood; 1991 Jul; 78(2):524-32. PubMed ID: 2070089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.